Please ensure Javascript is enabled for purposes of website accessibility

Amazon Is Creating Its Own COVID-19 Test for All Its Employees

By Donna Fuscaldo – Apr 16, 2020 at 1:59PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amazon CEO Jeff Bezos said the company began assembling the equipment to build its first lab and hopes to begin testing a limited number of frontline employees soon.

Amazon (AMZN -3.03%) is working on its own COVID-19 diagnostic test with an eye toward eventually testing its entire workforce. 

In the company's annual letter to shareholders, Amazon CEO Jeff Bezos said a team of Amazon research scientists, procurement specialists, and software engineers have been taken from their day jobs at the eCommerce company and are now focused on creating a test for the virus that's infected more than 640,000 people in the U.S.  

A person's hand wearing a glove and holding a syringe as the person tests a COVID-19 sample.

IMAGE SOURCE: GETTY IMAGES.

"A next step in protecting our employees might be regular testing of all Amazonians, including those showing no symptoms," wrote Bezos. "If every person could be tested regularly, it would make a huge difference in how we fight this virus. Those who test positive could be quarantined and cared for, and everyone who tests negative could reenter the economy with confidence." For that to work, Bezos argued there needs to be "vastly" more testing capacity than what is available today. 

Bezo said Amazon has begun assembling the equipment necessary to build its first lab and hopes to start testing a small number of its employees on the frontlines soon. The Amazon CEO acknowledged it's uncertain how far the tech giant will get in developing its own test and whether it will be in a relevant time frame but said it's worth trying. 

Bezo also reiterated what the online retailer has been doing to keep its employees safe during the pandemic, noting it has made more than 150 process changes. Those include distributing face masks, implementing temperature checks at locations around the world, regularly sanitizing touchpoints in its facilities, and instituting social distancing rules. 

Despite all those efforts, Amazon has faced criticism it's not doing enough to keep warehouse and delivery workers safe, which has prompted some workers to protest.  

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Donna Fuscaldo has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.

Stocks Mentioned

Amazon.com Stock Quote
Amazon.com
AMZN
$88.25 (-3.03%) $-2.76

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.